Current Trials

F04626 – Type 2 Diabetes & Weight Management Trial

 Fusion Clinical Research Norwood

Adults aged 18-79 who are living with overweight or obesity and have been diagnosed with Type 2 Diabetes may be eligible for a clinical trial evaluating an investigational weight management treatment over approximately 76 weeks.

The treatment is an oral tablet taken once daily.

The study involves 23 visits including screening and telehealth visits.

Sign up below to see if this study is suitable for you.

Screenshot 2026-05-27 at 5.05.27 pm

Eligibility requirements

  • Age: 18-79
  • Sex: M & F
  • BMI: ≥27
  • Weight: History of 1 self-reported unsuccessful dietary effort to lose weight and weight must be stable for the past 3 months without a change exceeding 5 kg
  • Medication: Must have a stable Type 2 Diabetes treatment for at least 90 days prior to screening, consisting of either diet and exercise alone or up to 3 oral diabetes medications. Must not be taking GLP-1 medications such as Ozempic or Mounjaro. Must not be taking insulin or other injectable diabetes therapies. Must not be taking DPP-4 inhibitor medications such as Trajenta or Januvia.
  • Medical History: Any ongoing illnesses, pre-existing conditions, allergies, and prior significant illnesses will be recorded. Must have a confirmed Type 2 Diabetes diagnosis with HbA1c between 6.5% and 10% at screening. Cannot have had 1 or more episode of severe hypoglycemia and/or 1 or more episode of hypoglycemia unawareness within 180 days prior to Screening.

Overnight Stays

  • Nil

Outpatient Visits

  • 23 visits including screening and telehealth visits

Payment/Remuneration

  • You will be reimbursed AUD $100 for each study visit. You may also be reimbursed up to $40 to cover the cost of a meal for study visits requiring fasting.

How to apply

To register your interest in this trial, please complete the form below, or call us on 1800-FUSION (1800 387 466). A Fusion team member will be in contact to discuss your eligibility shortly.